Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women.
about
Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotranspositionImplications of gender and pregnancy for antiretroviral drug dosingRole of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy.Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil.Pregnancy-related effects on lamivudine pharmacokinetics in a population study with 228 women.Antiretroviral therapy and mother-to-child transmission of HIV-1.Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine.Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.Antiretroviral bioanalysis methods of tissues and body biofluids.Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women.Managing mother-to-child transmission of HIV infection in developed-country settings.Chronic hepatitis B virus infection and pregnancy.Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence.Antiretroviral agents and acid-base balance at delivery of the neonate
P2860
Q33318459-90F6E57C-6B90-4F64-AF45-A44D82E06A2DQ33584069-47666914-3230-4422-AE6C-4CD58E37731CQ33954823-A59786C0-A476-4632-AE3A-B5538A4369DCQ34429204-42475665-6856-41E6-8568-E7FC9C3B0FD4Q35531092-DAEDA05F-F8DF-4C34-9CE4-95ECE68D3C92Q35689342-B2DB06BA-1EC2-4A92-B0E3-D9B3C48D63B9Q35917533-9CC6892F-293C-4CE5-A191-76F03FC5B607Q37203806-E94C195D-C5F4-4DCD-8533-D3FEB44BD0D9Q37204271-E61540FD-6B2E-4D4D-8570-870781ECE6CAQ37332868-9A236D96-2BDD-4EC7-BFC9-F1411FD0D4C1Q37598671-AF8F98BA-4698-4711-95AD-1442149ABFA5Q37608356-0146EFC6-7ED7-45E1-B6C8-23185F664490Q37613468-11E42672-458F-4C2D-BB21-3B7C72E8E3C8Q38051400-A5236C9F-F076-44EC-A1D3-8FB7D48D1C8FQ38260025-046717AC-E377-43D0-A8B6-782C6524AB98Q56982577-F6C53042-9728-4C79-9128-581F13DA52F9
P2860
Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Maternal-fetal transfer and am ...... virus-infected pregnant women.
@ast
Maternal-fetal transfer and am ...... virus-infected pregnant women.
@en
type
label
Maternal-fetal transfer and am ...... virus-infected pregnant women.
@ast
Maternal-fetal transfer and am ...... virus-infected pregnant women.
@en
prefLabel
Maternal-fetal transfer and am ...... virus-infected pregnant women.
@ast
Maternal-fetal transfer and am ...... virus-infected pregnant women.
@en
P2093
P356
P1476
Maternal-fetal transfer and am ...... virus-infected pregnant women.
@en
P2093
Farinotti R
Mandelbrot L
Peytavin G
P304
P356
10.1067/MOB.2001.108344
P407
P577
2001-01-01T00:00:00Z